Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Inhibition of Protein Synthesis by 8-Azaguanine I. Effects on Polyribosomes in HeLa Cells

ERNEST F. ZIMMERMAN and STEPHEN A. GREENBERG
Molecular Pharmacology September 1965, 1 (2) 113-125; DOI: https://doi.org/10.1124/mol.1.2.113
ERNEST F. ZIMMERMAN
Department of Pharmacology, Stanford University, School of Medicine, Palo Alto, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHEN A. GREENBERG
Department of Pharmacology, Stanford University, School of Medicine, Palo Alto, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In HeLa monolayer and suspension cultures azaguanine causes a preferential inhibition of protein synthesis; RNA and DNA synthesis are inhibited to a lesser extent and at later times. The effects of azaguanine were explored by measuring protein synthesis on the cytoplasmic polyribosomes that were isolated by sucrose gradient centrifugation. Azaguanine (3 x 10-4 M) after 24 hours pretreatment of HeLa, decreased protein synthesis per unit of polyribosome to 44% of control. The appearance of mRNA in polyribosomes of the drug-treated culture was not impaired. Synthesis of cytoplasmic ribosomes was suppressed by about 50-60%. Azaguanine was incorporated into both mRNA and ribosomal RNA molecules of the polyribosome structure.

Azaguanine (3 x 10-4 M) did not inhibit protein synthesis in rabbit reticulocytes even after 20 hours’ exposure to the drug.

It was concluded that azaguanine inhibits protein synthesis not by blocking the formation of polyribosomes but rather by incorporation into mRNA of this structure.

ACKNOWLEDGMENT This work was supported by a grant (T39) from the American Cancer Society to Dr. Avram Goldstein.

  • Copyright ©, 1965, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 1, Issue 2
1 Sep 1965
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Protein Synthesis by 8-Azaguanine I. Effects on Polyribosomes in HeLa Cells
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Inhibition of Protein Synthesis by 8-Azaguanine I. Effects on Polyribosomes in HeLa Cells

ERNEST F. ZIMMERMAN and STEPHEN A. GREENBERG
Molecular Pharmacology September 1, 1965, 1 (2) 113-125; DOI: https://doi.org/10.1124/mol.1.2.113

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Inhibition of Protein Synthesis by 8-Azaguanine I. Effects on Polyribosomes in HeLa Cells

ERNEST F. ZIMMERMAN and STEPHEN A. GREENBERG
Molecular Pharmacology September 1, 1965, 1 (2) 113-125; DOI: https://doi.org/10.1124/mol.1.2.113
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Effects of Small Molecule Ligands on ACKR3 Receptors
  • Michaelis-Menten Quantification of GPCR-G Protein Signaling
  • Anti-aromatase activity of exemestane phase II metabolites
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics